 |
|
|
 |
Event Co-Chairs
Paul Jacobs, Ph.D. | Katherine Kalin
Paul Jacobs, Ph.D.
Chairman of the Board, QUALCOMM
Paul Jacobs, Ph.D., is chief executive offi cer of QUALCOMM Incorporated and is
also a member of the Company's board of directors. Dr. Jacobs has been the primary
driver of QUALCOMM's focus on enabling wireless data services, which make the cell
phone a tool not only for voice communications, but also the most personal device for
entertainment, computing and information access.
Following completion of his Ph.D. in 1989, and a year as a post-doctoral researcher
at a French government lab in Toulouse, Dr. Jacobs joined the company full-time
in 1990, as a development engineer leading the cell phone digital signal processor
software team. His early work focused on the initial variable-rate 8 kbps speech codec
for CDMA. Following this effort, Dr. Jacobs spearheaded the wireline-quality 13 kpbs
speech codec effort, which became CDMAs initial differentiating consumer feature. The
core engineering team involved in this effort would later be integral to the development
of QUALCOMM's LaunchpadT suite of multimedia functions that ship as software
with every QUALCOMM chipset. Known as an innovative leader of a broad range of
technical teams within QUALCOMM, Dr. Jacobs has also been granted more than 25
patents for his inventions in the area of wireless technology.
In 1995, he became vice president and general manager of the combined handset
and integrated circuit division, which was subsequently divided into QUALCOMM
Consumer Products (QCP) and QUALCOMM CDMA Technologies, respectively. He was
named senior vice president of the Company in 1996 and president of QCP in 1997;
he was named executive vice president of QUALCOMM in 2000 and group president
of QWI in 2001. QCP developed and manufactured the wireless industry's fi rst CDMA
digital handsets, supporting the rapid global deployment of cdmaOne in the 1990s.
Under Dr. Jacobs, that business became the number two CDMA handset supplier in
the U.S. prior to its sale to Kyocera Wireless in 2000, with revenues of more than $1.4
billion in QUALCOMM's Fiscal 1999. At QCP, Dr. Jacobs gained extensive operational
experience, helped launch numerous CDMA systems and cultivated important
executive relationships at top network operators and manufacturers globally.
Other, important developments which began under Dr. Jacobs in QCP include the
fi rst Palm OS®-based smartphone (now a rapidly growing category of mobile devices,
with third-party operating systems, offered by numerous manufacturers). He started
QUALCOMM's initiative to include global positioning system (GPS) capabilities in cell
phones. This led to the acquisition of SnapTrackT and QUALCOMM's development
of gpsOneT, and drove the development of a uniform set of application programming
interfaces (API), to simplify the process of putting software on handsets. Dr. Jacobs
expanded this latter idea into the overall concept for the BREW® system. The system
included dynamic downloading of applications to cellphones, with checks for digital
signatures on the applications, to ensure the integrity of the content, and the business
ecosystem that enables BREW developers to engage operators globally and receive
payment for their applications. The BREW solution is now deployed by more than 40
operators around the world.
back to top »
Katherine Kalin
Vice President, Strategy
Office of Strategy & Growth,
Johnson & Johnson Corporate Katherine Kalin is Vice President, Strategy for Digital Health and Services,
Johnson & Johnson Corporate Development. She is responsible for driving the identification, development and execution of new business strategy in key growth areas.
As a senior healthcare executive, Katherine possesses a unique combination of commercial business leadership skills in marketing, sales, strategy and general management. Most recently, Katherine was Vice President, U.S. Marketing, ETHICON, Inc., a Johnson & Johnson Company. She also served a similar leadership role in marketing and sales for CardioVations, a division of ETHICON, Inc., focused on the minimally invasive cardiovascular surgery market.
In December 2002, Katherine joined Johnson & Johnson from McKinsey & Company, where she was a partner in the global healthcare consulting practice. During her 12-year career at McKinsey, Katherine worked with a diverse range of healthcare companies in pharmaceuticals, devices and consumer products.
Katherine holds an M.B.A. from Harvard Business School and a B.A. degree in French from the University of Durham in the United Kingdom. She is fluent in French, Spanish and English.
back to top »
|
|
